telehealth
-
Wegovy Pill Copy: Hims & Hers Shakes Weight-Loss Drug Market
Telehealth company Hims & Hers announced it will offer a $49 copy of Novo Nordisk’s popular Wegovy pill, causing significant shifts in the stock market for major pharmaceutical firms.
-
VSee Health Stock Surges After FedRAMP High Authorization: What Investors Need to Know
VSee Health’s stock soared after receiving FedRAMP High authorization, paving the way for expanded government partnerships. This major security certification brings new opportunities—and risks—for investors navigating a volatile healthcare tech sector.
-
Talk Therapy Usage Rises, Psychiatric Medication Alone Declines: Study
A new study shows a rise in talk therapy usage among U.S. adults while reliance on psychiatric medication alone has declined.